John Oyler
Chief Executive Officer at BeOne Medicines Ltd.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: BeOne Medicines Ltd., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BeOne Medicines Ltd. June 11, 202698.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2026 | BeOne Medicines Ltd. | Open-market sale | −1,980 | $354.71 | $702,326 |
| Aug 12, 2026 | BeOne Medicines Ltd. | Open-market sale | −2,515 | $356.43 | $896,421 |
| Aug 12, 2026 | BeOne Medicines Ltd. | Open-market sale | −15,396 | $357.63 | $5,506,071 |
| Aug 12, 2026 | BeOne Medicines Ltd. | Open-market sale | −20,899 | $358.41 | $7,490,411 |
| Aug 12, 2026 | BeOne Medicines Ltd. | Open-market sale | −14,102 | $359.12 | $5,064,310 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −13,695 | $359.32 | $4,920,887 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −8,081 | $360.33 | $2,911,827 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −14,569 | $361.47 | $5,266,256 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −11,568 | $362.34 | $4,191,549 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −13,403 | $363.45 | $4,871,320 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −5,211 | $364.31 | $1,898,419 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −3,176 | $365.26 | $1,160,066 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −1,200 | $366.31 | $439,572 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −4 | $367.00 | $1,468 |
| Aug 10, 2026 | BeOne Medicines Ltd. | Open-market sale | −67 | $350.00 | $23,450 |
Questions about John Oyler
What boards is John Oyler on?
John Oyler sits on the board of BeOne Medicines Ltd.
What company is John Oyler the CEO of?
John Oyler is Chief Executive Officer of BeOne Medicines Ltd.
How long has John Oyler served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.